Home Your basket
• Oto-rhino-laryngology and...
   Price 10.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Voice prostheses: long-te...
   Price 10.50 €
• Phoniatric management of ...
   Price 8.50 €
• Combined transoral and su...
   Price 10.50 €
• Migraine, neurone and ves...
   Price 5.50 €
• Recurrent mandibular amel...
   Price 12.50 €
• Influence of Platelet Ric...
   Price 10.50 €
• Diagnostic value of fine-...
   Price 8.50 €
• Evaluation of the handica...
   Price 10.50 €
• Cataract surgery and its ...
   Price 10.50 €
• Quality of life before an...
   Price 10.50 €
• Velo-pharyngeal incompete...
   Price 14.00 €
• Newborn and infant nasal ...
   Price 5.50 €
• Covering of parotid and c...
   Price 14.00 €
• Periphery, central and ps...
   Price 10.50 €
• The pedicled musculo-cuta...
   Price 8.50 €
• The symphonix symposium u...
   Price 8.50 €
• The prevention of voice d...
   Price 10.50 €
• Vocal effectiveness in sp...
   Price 10.50 €
• Supra and infra hyoid mid...
   Price 10.50 €
• External otitis...
   Price 8.50 €
• Late metastasis from rena...
   Price 8.50 €
• Formant structures of vow...
   Price 10.50 €
• Post-operative evaluation...
   Price 10.50 €
• Laryngeal schwannomas...
   Price 5.50 €
• Observational study to as...
   Price 14.00 €
• Vertebro and cranio veino...
   Price 14.00 €
• Research in cancer : adva...
   Price 5.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Analysis of the possibili...
   Price 8.50 €
• Fibrous dysplasia, a case...
   Price 10.50 €
• International Conference ...
   Price 5.50 €
• Carotid body paragangliom...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• Objective analysis of pos...
   Price 8.50 €
• Prognostic value of mandi...
   Price 10.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Protruding ears...
   Price 8.50 €
• Time-intensity trade of b...
   Price 10.50 €
• Parathyroid carcinoma: di...
   Price 5.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• Medical rhinoplasty: Rati...
   Price 10.00 €
• Non-Hodgkin's lymphoma of...
   Price 5.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• CT scan, MR imaging and a...
   Price 10.50 €
• Role of positron emission...
   Price 15.00 €
• Explorations of the velum...
   Price 14.00 €
• Association of thyroid he...
   Price 12.50 €
• Post-operative complicati...
   Price 10.50 €
• Going from the tube feedi...
   Price 8.50 €
• Fronto-ethmoidal fibrous ...
   Price 8.50 €
• Quality of life evaluatio...
   Price 10.50 €
• Mucus physiopathology, up...
   Price 12.50 €
• Autologous fat graft for ...
   Price 14.00 €
• Lipoma of the floor of th...
   Price 10.50 €
• Frontal sinus osteoma and...
   Price 5.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• Nasal involvement in Croh...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Cemento-ossifying fibroma...
   Price 8.50 €
• Transgender voice and com...
   Price 12.00 €
• The relevance of Choukrou...
   Price 10.50 €
• A rare and unusual cause ...
   Price 8.50 €
• Planned reconstruction af...
   Price 8.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• A study of peristomal rec...
   Price 5.50 €
• The three-stage frontal f...
   Price 14.00 €
• Free novascularized bone ...
   Price 15.00 €
• Mucosal melanomas of the ...
   Price 8.50 €

Total Order 694.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2004 o

ONCOLOGY

Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie’s patients and patient’s follow up with laryngeal preservation


Authors : J. P. Bessède, D. Vinh, D. Genet, N. Khalifa, K. Aubry, B. Rhein, S. Orsel, N. Tubiana-Mathieu, P. Clavère (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2004;125,2:81-88.

Article published in french
Downloadable PDF document french



Summary : Objective: To try and determine the value of chemotherapy and its subsequent effect on laryngeal preservation in patients presenting with laryngeal and pharyngeal carcinomas. One group was initially treated with surgery and radiotherapy. The second group was treated with chemotherapy and subsequent salvage surgery and/or radiotherapy. Their survival rates and laryngeal preservation rates were compared. Patients and methods: From 251 patients the authors have retrospectively studied 124 patients with induction chemotherapy. The survival rate has been compared with a control group of 127 patients who was treated by initial surgery and radiotherapy. Results: The survival rate at 5 years for the patients initialy treated by surgery and radiotherapy was 64.1%. The survival for patients with a total clinical response following chemotherapy was 49.8% at 5 years. Survival with no total clinical response following chemotherapy treated by secondary radiotherapy was 25.7% at 3 years. The initial rate of laryngeal preservation is 32.2% but this rate fell to 22% after local recurrencies. Conclusion: The group with total clinical response after induction chemotherapy with laryngeal preservation have a non significantly difference in their survival compared with the group initially treated by surgery and radiotherapy. In contrary patients with non complete clinical response have a survival of 25.7% at 3 years. The rate of local recurrency of patients with laryngeal preservation is 32.5% and gives a finally rate of laryngeal preservation of 21%. These recurrencies decrease the survival rate.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE